phosphatidylcholines has been researched along with geranylgeranyl pyrophosphate in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (geranylgeranyl pyrophosphate) | Trials (geranylgeranyl pyrophosphate) | Recent Studies (post-2010) (geranylgeranyl pyrophosphate) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 518 | 3 | 203 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Detrick, MS; Dvoracek, LA; Francis, AD; Kacmarik, KL; Kreisberg, JI; Kreisberg, R; Lee, HM; McKinney, J; Primerano, DA; Santanam, N; Schmid, G | 1 |
1 other study(ies) available for phosphatidylcholines and geranylgeranyl pyrophosphate
| Article | Year |
|---|---|
Lovastatin inhibits oxidized L-A-phosphatidylcholine B-arachidonoyl-gamma-palmitoyl (ox-PAPC)-stimulated interleukin-8 mRNA and protein synthesis in human aortic endothelial cells by depleting stores of geranylgeranyl pyrophosphate.
Topics: Aorta; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Humans; Interleukin-8; Lovastatin; Phosphatidylcholines; Polyisoprenyl Phosphates; Protein Biosynthesis; RNA, Messenger | 2010 |